LENSAR, Inc.'s ALLY Robotic Cataract Laser System has driven significant revenue and earnings growth. Read why LNSR stock is ...

The options are subject to the terms and conditions of LENSAR’s 2024 Employment Inducement Incentive Award Plan and a stock option agreement covering the grant. LENSAR is a commercial-stage medical ...

AI has quietly revolutionized the field of ophthalmology.While the concept of AI may evoke futuristic images of robots and ...

("LENSAR" or "the Company"), a global medical technology company focused on advanced laser solutions for the treatment of cataracts, today announced that the ALLY Adaptive Cataract Treatment ...

In a remarkable display of market confidence, LENSAR Inc. (LNSR) stock has achieved a new 52-week high, with shares trading at $9.25. This peak represents a significant milestone for the company, ...

LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and ...

ORLANDO, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors ...

ORLANDO, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of ...